Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Consolidated Interim Balance Sheets

v3.19.2
Condensed Consolidated Interim Balance Sheets - USD ($)
Jun. 30, 2019
Dec. 31, 2018
CURRENT ASSETS:    
Cash and cash equivalents $ 39,201 $ 144,948
Restricted cash 15,423 14,674
Accounts receivable, net 122,730 200,776
Other current assets 81,141 65,011
Inventory, net 117,593 53,344
Total current assets 376,088 478,753
NON-CURRENT ASSETS:    
Property and equipment, net 275,472 300,702
Intangible asset, net 3,607,628 3,821,844
Goodwill 3,026,036 3,026,036
Total non-current assets 6,909,136 7,148,582
Total assets 7,285,224 7,627,335
CURRENT LIABILITIES:    
Short term bank credit 53,748
Short-term loans 14,024
Trade payables 673,210 709,269
Employees and payroll accruals 430,753 359,273
Accrued expenses and other current liabilities 604,179 842,142
Convertible loans 319,380 226,661
Total current liabilities 2,095,294 2,137,345
NON-CURRENT LIABILITIES:    
Capital note 35,777 32,000
Convertible loans 3,244,382 1,809,816
Warrants presented at fair value 1,289,388 945,025
Total non-current liabilities 4,569,547 2,786,841
Total liabilities 6,664,841 4,924,186
SHAREHOLDERS' EQUITY:    
Ordinary shares of NIS 0.01 par value - Authorized: 200,000,000 ordinary shares as of June 30, 2019 and December 31, 2018, respectively; Issued and outstanding: 24,033,660 and 23,491,948 ordinary shares as of June 30, 2019 and December 31, 2018, respectively 64,815 63,301
Additional paid in capital 19,842,626 19,698,606
Accumulated deficit (19,287,058) (17,058,758)
Total shareholders' equity 620,383 2,703,149
Total liabilities and shareholders' equity $ 7,285,224 $ 7,627,335